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This Letter describes glycosylation of 4-Nerolidylcatechol (4-NRC) the major secondary metabolite from
Pothomorphe peltata and Pothomorphe umbellata showing remarkable antioxidant, antimalarial, anti-
inﬂammatory, and anti-HIV activities. One step biosynthesis was catalyzed by Cunninghamella echinulata
ATCC 9245 and the reaction was undertaken in PDSM medium at 27 C, 200 rpm for 96 h. After puriﬁca-
tion by silica gel ﬂash column chromatography the 4-NRC b-glycoside was identiﬁed by ultrahigh reso-
lution mass spectrometry and 1H NMR. The antioxidant activity was evaluated by differential pulse
voltammetry.
 2013 Elsevier Ltd. All rights reserved.4-Nerolidylcatechol (4-NRC) is the major secondary metabolite
from Pothomorphe peltata and Pothomorphe umbellata traditionally
used for the treatment of hepatic disorders in Brazilian Southwest
and Amazon area.1 Pharmacological studies have shown remark-
able antioxidant,2 antimalarial,3 anti-inﬂammatory,4 and anti-HIV
activities.5 Despite of its promising pharmaceutical proﬁle, the
instability often presents a shortcoming for its medical applica-
tions. Glycosylation is useful for preparing more stable glycosides
from unstable compounds; improving their bioavailability and
pharmacological properties.
Usually, the glycosylation reactions by classical organic chemis-
try are conducted in four steps. First, the per-O-acetylation of glu-
cose is carried out, followed by halogenation at anomeric per-O-
acetylation of glucose position. Next a Lewis acid catalizes the
reaction of the target compound with 2, 3, 4, 6-tetra-O-acetyl-a-
D-glucopyranosyl bromide and the glycosylated compound is
unprotected in the presence of sodium methoxide.6,7
Examples of oxidation, reduction, and glycosylation reactions
using ﬁlamentous fungi as catalysts have been reported in the lit-
erature.8,9 One of the beneﬁts of using the microbial metabolism
system, instead of the traditional or chemical synthesis, is the pos-
sibility of production of several metabolites or derivatives drugs
that are difﬁcult to be synthesized.10 Glycosylation is an example
of a reaction that takes several steps in chemical synthesis and
via microbial reactions can be done in a single step, also under mild
reaction conditions.11,6Cunninghamella is a ﬁlamentous fungus typically found in soil
and plant material, they are able to metabolize a wide range of
xenobiotics in a regio- and stereo-selective manner. Generally,
the fungi produce a metabolite by a mode similar to those in mam-
malian enzyme system.12 It is known that the Cunninghamella has
the ability to perform a variety of selective reactions, including
phase I (oxidative) and phase II (conjugative) biotransforma-
tion.13,14 There are a great number of studies describing the ability
of ﬁlamentous fungi of the species C. echinulata to biotransform
drugs, including aromatic xenobiotics, one of the Cunninghamella
strains, Cunninghamella echinulata ATCC 9245, has been an impor-
tant microorganism to perform b-glycosylation reactions.15,16
Then, the C. echinulata appears as a promising tool for the produc-
tion of molecules with improved, different, or less toxic activities.
Glycoside is probably obtained by the action of fungal glycosidase
to a direct reaction using a primary or secondary alcohol as a
nucleophile.17
The aim of this study was to perform the glycosylation of 4-NRC
(1)18 using the ﬁlamentous fungi, C. echinulata ATCC 9245 for fur-
ther evaluation of similar, new pharmacological activities, and tox-
icological studies of 4-NRC b-glycoside
A spore suspension of Cunninghamella echinulata ATCC 9245
strain (American Type Culture Collections) incubated at 27 C for
7 days on potato agar, was transferred to liquid culture medium.
Incubation was performed in ten 250 mL Erlenmeyer ﬂasks con-
taining 100 mL of culture medium (5 g bacteriological peptone,
5 g soy lecithin, 5 g KH2PO4, 5 g NaCl, 20 g dextrose, and 3 g yeast
extract) and grown at 27 ± 1 C, 200 rpm for 65 h. After the growth
of mycelium 1 mL of the ethanolic solution of 1 (25 mg ml1) was
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Scheme 1. Glycosylation of 4NRC by Cunninghamella echinulata ATCC 9245.
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and the microorganism control. The substrate control was carried
out with culture medium and substrate under the same incubation
conditions; on the other hand the microorganism control was done
with microorganism and its culture medium without addition of
substrate. Aliquots were withdrawn every 24 h during a period of
96 h. The samples were extracted with ethyl acetate and spotted
on 0.25 mm thick silica gel GF254 plates (Whatman) and chromato-
graphed with ethyl acetate:methanol (95:05). The TLC plates were
visualized by ﬂuorescence under 254 nm UV light and with iodine
steam. The ﬂasks were brought together to conduct the extraction,
mycelium was ﬁltrated and extracted with acetone. The ﬁltrate
was saturated with NaCl and ﬁltered through Celite, proceeding
by the extraction with ethyl acetate three times. The extracts were405.05859
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Figure 1. ESI() FT-ICR MSconcentrated in vacuum. Puriﬁcation was performed by silica gel
column chromatography (2 cm  20 cm) eluting with ethyl ace-
tate:methanol (95:05).
The product 2 (Scheme 1) was characterized by Fourier-trans-
form ion cyclotron resonance mass spectrometry (FT-ICR MS). This
technique plays an important role for high accuracy mass measure-
ments at ultrahigh resolution in many scientiﬁc and industrial
areas.19 Very high accurate mass measurements at the part-
per-billion (ppb) level on product ions enable high conﬁdent
determination of the elemental composition as unambiguous
assignments of fragment ions. Typically, exact mass measurements
at high resolution are used to determine the elemental composi-
tion of a compound which is either unknown or the by-products
or metabolites of a known compound.20 For characterization by
FT-ICR MS, the compound 2 was dissolved in 1 mL of methanol.
For ESI in the negative mode, 2 lL of an aqueous solution of 1%
ammonium hydroxide was added to the solution and analyzed
by 9.4 T Solarix mass spectrometer (Bruker Daltonics, Bremen,
Germany). Fig. 1 displays the ESI() FT-ICR mass spectrum of 2.
Note the detection of 2 the [MH] anion of m/z 475.27024 with
the characteristic cluster of isotopologue ions. Compound 2 was
measured with exceptional mass accuracy, 240 ppb of the exact
mass. The molecular formula assigned to the ion of m/z
475.27024, C27H39O7, closely matches with the molecular formula
of the deprotonated ion of compound 2. This match corroborates
the proposed structure for the compound 2.
The 1H NMR analyses were obtained on a Bruker Avance III 500
instrument (operating at 500.13 MHz for 1H). NMR spectra of 1
were recorded in CDCl3 and its product in CD3OD using tetra-
methyl silane (TMS) as an internal standard. Compound 2
(Scheme 1) presented one additional glucose unit characterized
by typical 1H NMR signals at d 4.69 (d, J = 7.5 Hz, 1H), 3.87 (dd,
J = 12.1, 5.1 Hz, 1H), 3.74 (dd, J = 12.1, 2.4 Hz), 3.50 (dd, J = 9.8,
7.5 Hz, 1H), 3.36 (ddd, J = 7.4, 5.1, 2.4 Hz, 1H) and multiplets in
the d 3.433.52 region (Table 1). The glucose b-conﬁguration
was conﬁrmed through its coupling constant (J = 7.5 Hz), and its
position was determined by 2D NMR and NOE experiments. In
the former experiment, a cross-peak between the anomeric
hydrogen at d 4.69 and the carbon at d 146.6 (C-30) was observed.C27H39O7
Error = 240 ppb
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of 4-NRC b-glycoside.
Table 1
1H and 13C NMR spectral data for 4-Nerolidylcatechol and 4-Nerolidylcatechol-30-b-O-glycoside
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d1H (multiplicity, J Hz) d13C d1H (multiplicity, J Hz) d13C
1a 5.01 (dd, 17.5, 1.4) 111.7 5.00 (dd, 17.5, 1.4) 112.2
1b 5.06 (dd, 10.8, 1.4) 111.7 5.05 (dd, 10.8, 1.4) 112.2
2 5.97 (dd, 17.5, 10.8) 147.2 6.02 (dd, 17.5, 10.8) 149.1
3 — 43.9 — 44.9
4 1.75, 1.64 (m) 39.9 1.75, 1.64 (m) 42.5
5 1.85, 1.77 (m) 26.9 1.85, 1.77 (m) 24.4
6 5.10 (m) 124.7 5.09 (m) 126.0
7 — 135.2 — 135.8
8 1.94 (t, 7.2) 41.3 1.94 (t, 7.2) 40.8
9 2.04 (dt, 7.8, 7.2) 25.9 2.04 (dt, 7.8, 7.2) 27.8
10 5.09 (m) 124.5 5.07 (m) 125.4
11 — 131.6 — 132.1
12 1.67 (dq, 1.1, 0.4) 25.1 1.65 (dq, 1.1, 0.4) 25.8
13 1.31 (s) 23.3 1.34 (s) 25.4
14 1.51 (d, 0.8) 16.1 1.49 (d, 1.3) 16.2
15 1.59 (dq, 1.0, 0.4) 17.9 1.59 (dq, 1.0, 0.4) 17.9
10 — 141.1 — 140.6
20 6.84 (d, 2.3) 115.2 7.17 (d, 2.3) 118.3
30 — 143.2 — 146.6
40 — 141.4 — 146.4
50 6.79 (d, 8.4) 114.4 6.77 (d, 8.4) 116.9
60 6.74 (dd, 8.4, 2.3) 119.3 6.88 (dd, 8.4, 2.3) 123.4
1’’ — — 4.69 (d, 7.5) 105.1
2’’ — — 3.50 (dd, 9.8, 7.5) 75.2
3’’ — — 3.45 (m) 78.0
4’’ — — 3.46 (m) 71.4
5’’ — — 3.36 (ddd, 7.4, 5.1, 2.4) 78.6
6’’a — — 3.74 (dd, 12.1, 2.4) 62.6
6’’b — — 3.87 (dd, 12.1, 5.1) 62.6
OH 5.64 (br s) — — —
1H and 13C NMR assignments are based on 1H and 1H–13C HMBC spectra at 500 MHz and 125 MHz. Measured in CDCl3 for 1 and CD3OD for 2.
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Figure 2. Differential pulse voltammetry analysis obtained in the solid state for 1
(——) and 2 (---) immobilized on a carbon paste electrode of 0.5 mm diameter in
phosphate buffer, 0.1 M, pH 7.0. Pulse amplitude of 50 mV, scan rate of 10 mV/s.
6658 K. C. F. Araújo Cordeiro et al. / Tetrahedron Letters 54 (2013) 6656–6659The cross-peaks of H-200 with C-100 and C-300, H-300 with C-200, H-400
with C-200 and C-300, and H-600 with C-400 and C-500 were also
observed. The correlation between anomeric hydrogen (H-100) and
H-20 in the NOE spectrum reinforced the assignment of glycosyla-
tion at the C-30 position.
In order to evaluate the antioxidant activity of 2 we performed
the analysis using differential pulse voltammetry. Compound 2
(Fig. 2) also showed two anodic peaks, the ﬁrst and second at peak
potentials, Ep1a and Ep2a, respectively at 348 mV and 629 mV, and
current spikes 17 and 13 lA. The negative shift of more than
200 mV shows that compound 2 results in greater reducing power.
Though, the glycosylation process has occurred at 30 hydroxyl
group, leading to the modiﬁcation of the cathecol group to mono
phenol pattern, the peak potential, 1a, at Epa <0.4 V is very low,
thus having a great electron donor behavior and promising antiox-
idant activity.
In conclusion, we show a promising application of ﬁlamentous
fungi C. echinulata ATCC 9245, exempliﬁed here by the glycosyla-
tion of 1. The differential pulse voltammetry results conﬁrm that
2 maintains the antioxidant activity, which associated with their
better solubility and stability can result in improved biologicalactivities than its precursor 1. These results were obtained in accor-
dance with the principles of green chemistry, the experimental
K. C. F. Araújo Cordeiro et al. / Tetrahedron Letters 54 (2013) 6656–6659 6659conditions have little environmental impact, and the solvents are
renewable and economical.
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